Molnupiravir: From Press Release to Practice

from Saving Lives Podcast: Critical Care w/eddyjoemd · host Eddy Joe Gutierrez, MD

Molnupiravir is a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2 made by Merck that helps COVID patients. Show Notes: https://eddyjoemd.com/molnupiravir/ Although great care has been taken to ensure that the information in this podcast are accurate, eddyjoe, LLC shall not be held responsible or in any way liable for the continued accuracy of the information, or for any errors, omissions or inaccuracies, or for any consequences arising therefrom. Website: www.eddyjoemd.com Instagram: www.instagram.com/eddyjoemd Twitter: www.twitter.com/eddyjoemd Facebook: www.facebook.com/eddyjoemd Podcast: https://anchor.fm/eddyjoemd My Amazon store for resources you may find helpful: www.amazon.com/shop/eddyjoemd

Episode metadata supplied by the publisher feed · Published Oct 2, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Molnupiravir: From Press Release to Practice

0:00 10:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Saving Lives Podcast: Critical Care w/eddyjoemd?

This episode is 10 minutes long.

When was this Saving Lives Podcast: Critical Care w/eddyjoemd episode published?

This episode was published on October 2, 2021.

Can I download this Saving Lives Podcast: Critical Care w/eddyjoemd episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!